This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Jale Muslehiddinoglu, PhD
Vice President of Strategic Innovation at ST Pharm
Speaker

Profile

Jale Muslehiddinoglu, Ph.D. is Vice President of Strategic Innovation at ST Pharm, with 23 years of experience in biotech, pharmaceutical, and CDMO sectors. For the past 2.5 years, she has contributed to expanding ST Pharma's capabilities, driving innovation in oligonucleotide process development and manufacturing.

Before joining ST Pharm, Jale played a key role in establishing lab and production capabilities for oligonucleotide therapeutics, spanning development, manufacturing, and supply chain. She has introduced innovative process development strategies and was part of the team that initiated EPOC, and is currently on the organizing committee for multiple oligonucleotide events.

Jale holds a Ph.D. in Chemical Engineering from Pennsylvania State University.

Agenda Sessions

  • Panel Discussion

    11:15